These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38622522)

  • 1. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
    Liu SS; Wan QS; Lv C; Wang JK; Jiang S; Cai D; Liu MS; Wang T; Zhang KH
    BMC Cancer; 2024 Apr; 24(1):465. PubMed ID: 38622522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Clinical Significance of ILF2 in Gastric Cancer.
    Yin ZH; Jiang XW; Shi WB; Gui QL; Yu DF
    Dis Markers; 2017; 2017():4387081. PubMed ID: 28831206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 4. Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.
    Liu JY; Dong XX; Lu JN; Zhang Y; Liu KF; Liu LF; E QZ; Lu XJ; Yin JY; Shen YP
    FEBS Open Bio; 2019 Jan; 9(1):35-42. PubMed ID: 30652072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
    Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
    Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.
    Zhang X; Bustos MA; Gross R; Ramos RI; Takeshima TL; Mills GB; Yu Q; Hoon DSB
    Clin Transl Med; 2021 Oct; 11(10):e608. PubMed ID: 34709752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
    Zhao X; Wu S; Jing J
    Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrin β5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis and immunotherapy efficacy in gastric cancer.
    Cheng Y; Lin X; Xu H; Xu M; Xie W; Zeng J; Cui B; Cheng Z; Zhao J; Sun Y
    BMC Gastroenterol; 2024 Oct; 24(1):362. PubMed ID: 39394072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
    Chen M; Zhu X; Zhang L; Zhao D
    BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer.
    Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y
    PeerJ; 2024; 12():e17130. PubMed ID: 38515458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and
    Duan H; Chen B; Wang W; Luo H
    Aging (Albany NY); 2023 Feb; 15(5):1445-1474. PubMed ID: 36863706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
    Zhu C; Xiao D
    Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
    Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
    J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
    Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
    Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
    Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
    Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.
    Dai J; Li ZX; Zhang Y; Ma JL; Zhou T; You WC; Li WQ; Pan KF
    Clin Transl Gastroenterol; 2019 Jan; 10(1):e00004. PubMed ID: 30702489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer.
    Li Y; Wang M; Yang M; Xiao Y; Jian Y; Shi D; Chen X; Ouyang Y; Kong L; Huang X; Bai J; Hu Y; Lin C; Song L
    Cancer Res; 2021 Jul; 81(13):3525-3538. PubMed ID: 33975879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.